Insilico Medicine
also invests · investor profileBaltimore, US · Founded 2014 · Delaware corporation · 19 employees on LinkedIn · 6 known investors
This page is a thought-leadership essay by Teymour Boutros-Ghali of Bold Capital Partners arguing that venture investors and foundations should fund the commercialization phase of health-equity-focused life science companies using non-dilutive capital. It is an opinion article rather than a description of a specific product or company.
Founders & leadership
Insilico Medicine was founded in 2014 by Aleksandrs Zavoronkovs.
AZ
Aleksandrs ZavoronkovsFounder
Investors · 6
.jpeg){kind=logo}
Reported raises · per SEC filings
Form D private placements$12.8M disclosed across 3 rounds · 2016–2018
▶$6MraisedJun 2018 · 15 investors · BiotechnologyRule 506(b)
▶$6MraisedJun 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex ZhavoronkovExecutive Officer, Director
- James MellonDirector
- Qingsong ZhuExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedJul 2017 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedJul 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $4M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.8MraisedJul 2017 · 17 investors · BiotechnologyRule 506(b)
▶$2.8MraisedJul 2017 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $25K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Superscout35 shared keywordsSuperscout runs a scout network that connects people who spot promising startups with venture capital partners, paying scouts a share when a referred startup receives funding from its partners. It targets aspiring investors, university entrepreneurship communities, accelerator staff, and researchers, and provides scouting resources, guides, and a community.
Waveup33 shared keywordsWaveup is an advisory firm that helps startups and high-growth companies raise capital and prepare for M&A, building pitch decks, financial models, investor narratives, CIMs, and go-to-market strategies. It serves founders from pre-seed through Series D+ across many industries, offering fundraising, business growth, and exit-positioning consulting.
Companies competing with Insilico Medicine for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths | The Manila Timesmanilatimes.net · Aug 2026
Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science - BioSpacebiospace.com · Jul 2026Frequently asked questions
- What does Insilico Medicine do?
- This page is a thought-leadership essay by Teymour Boutros-Ghali of Bold Capital Partners arguing that venture investors and foundations should fund the commercialization phase of health-equity-focused life science companies using non-dilutive capital. It is an opinion article rather than a description of a specific product or company.
- Who founded Insilico Medicine?
- Insilico Medicine was founded by Aleksandrs Zavoronkovs in 2014.
- Who are Insilico Medicine's investors?
- Insilico Medicine's investors include B Capital Group, Bold Capital Partners, BOLD Longevity, Harmonix Fund, LongeVC, SquareOne Capital.
- How much funding has Insilico Medicine raised?
- Insilico Medicine has disclosed $12.8M raised across 3 rounds.
- Where is Insilico Medicine headquartered?
- Insilico Medicine is headquartered in Baltimore, US.